ARTICLE | Clinical News
Prezista darunavir regulatory update
July 30, 2012 7:00 AM UTC
EMA's CHMP issued a positive opinion to expand the indication of Prezista darunavir from Johnson & Johnson to include treatment of HIV-1 infection in antiretroviral therapy-experienced pediatric patie...